Healthkeeperz Location: 4155 Ferncreek Drive, Fayetteville, North Carolina 28304 Ratings: Phone: (910) 860-4764 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Cape Fear Valley Home Health Location: 3400 Walsh Drive Suite 100, Fayetteville, North Carolina 28311 Ratings: Phone: (910) 609-6740 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Amedisys Home Health Of Fayetteville Location: 2021 Valley Gate Drive Suite 201, Fayetteville, North Carolina 28304 Ratings: Phone: (910) 483-6144 Health Services: Nursing Care, Physical Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Five Points Home Health Location: 3107 Raeford Road, Fayetteville, North Carolina 28303 Ratings: Phone: (910) 323-3628 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Liberty Home Care Location: 1830 Owen Drive Suite 103, Fayetteville, North Carolina 28304 Ratings:NA Phone: (910) 864-8411 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.
Dr Guishui Zhang and Associate Professor Levon Khachigian, from the Centre for Vascular Research, and Dr Nick Di Girolamo of the School of Medical Sciences were part of a team which suppressed a protein in the cells lining blood vessels.
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
A new study, led by Felix Aigner, M.D., has identified a protein known as Lipocalin-2 (Lcn-2) as potentially responsible for regulating the body's inflammatory response during heart transplants.
› Verified 3 days ago